{"id":3048,"date":"2024-03-13T14:58:43","date_gmt":"2024-03-13T11:58:43","guid":{"rendered":"https:\/\/pharmaworlddergi.com\/?p=3048"},"modified":"2024-03-13T14:58:44","modified_gmt":"2024-03-13T11:58:44","slug":"turkiyede-68-binden-fazla-diyaliz-hastasi-var","status":"publish","type":"post","link":"https:\/\/pharmaworlddergi.com\/?p=3048","title":{"rendered":"T\u00fcrkiye\u2019de 68 Binden Fazla Diyaliz Hastas\u0131 Var \u00a0"},"content":{"rendered":"\n

T\u00fcrk Nefroloji Derne\u011fi, kronik b\u00f6brek hastal\u0131\u011f\u0131n\u0131n \u00f6nemine dikkat \u00e7ekmek i\u00e7in belirlenen D\u00fcnya B\u00f6brek G\u00fcn\u00fc kapsam\u0131nda t\u00fcm y\u00f6netim kurulu \u00fcyelerinin kat\u0131l\u0131m\u0131yla \u201cB\u00f6brek Cand\u0131r\u201d temal\u0131 bir bas\u0131n toplant\u0131s\u0131 d\u00fczenledi. Bas\u0131n toplant\u0131s\u0131nda kronik b\u00f6brek hastal\u0131\u011f\u0131na dair toplumda fark\u0131ndal\u0131k sa\u011flamak, kronik b\u00f6brek hastal\u0131\u011f\u0131na yol a\u00e7an risk fakt\u00f6rleri ve erken tan\u0131n\u0131n b\u00f6brek fonksiyonunu korumadaki \u00f6nemine dikkat \u00e7ekmek \u00fczere bilgiler payla\u015f\u0131ld\u0131.<\/strong><\/sup><\/strong><\/p>\n\n\n\n

Her y\u0131l mart ay\u0131n\u0131n ikinci per\u015fembe g\u00fcn\u00fc olarak belirlenen D\u00fcnya B\u00f6brek G\u00fcn\u00fc\u2019nde kronik b\u00f6brek hastal\u0131\u011f\u0131n\u0131n \u00f6nemine dikkat \u00e7ekiliyor. T\u00fcrk Nefroloji Derne\u011fi bu y\u0131lki D\u00fcnya B\u00f6brek G\u00fcn\u00fc kapsam\u0131nda \u201cB\u00f6brek Cand\u0131r\u201d temas\u0131 alt\u0131nda Dernek Ba\u015fkan\u0131 Prof. Dr. Alaattin Y\u0131ld\u0131z, Ba\u015fkan Yard\u0131mc\u0131s\u0131 Prof. Dr. Nurhan Seyahi, Genel Sekreteri Prof. Dr. Elif Ar\u0131 Bak\u0131r, Sayman\u0131 Prof. Dr. Ali R\u0131za Odaba\u015f\u2019\u0131n yan\u0131 s\u0131ra Y\u00f6netim Kurulu \u00dcyeleri Prof. Dr. Mustafa Ar\u0131c\u0131, Prof. Dr. \u00d6zkan G\u00fcng\u00f6r, Prof. Dr. Sena Ulu\u2019nun kat\u0131l\u0131m\u0131 ve AstraZeneca T\u00fcrkiye\u2019nin ko\u015fulsuz katk\u0131lar\u0131yla bir bas\u0131n toplant\u0131s\u0131 d\u00fczenledi.<\/p>\n\n\n\n

Toplant\u0131da kronik b\u00f6brek hastal\u0131\u011f\u0131na dair toplumda fark\u0131ndal\u0131k sa\u011flamak, kronik b\u00f6brek hastal\u0131\u011f\u0131na yol a\u00e7an risk fakt\u00f6rleri ve erken tan\u0131n\u0131n b\u00f6brek fonksiyonunu korumadaki \u00f6nemine dikkat \u00e7ekmek \u00fczere bilgiler payla\u015f\u0131ld\u0131. Buna g\u00f6re d\u00fcnya genelinde yakla\u015f\u0131k 850 milyon kronik b\u00f6brek hastas\u0131 bulunuyor. T\u00fcrkiye\u2019de ise bu y\u0131l itibar\u0131yla 68 binin \u00fczerinde hasta son d\u00f6nem b\u00f6brek yetersizli\u011fi nedeniyle diyaliz tedavisi g\u00f6r\u00fcyor. \u00d6te yandan do\u011furma \u00e7a\u011f\u0131ndaki kad\u0131nlar\u0131n y\u00fczde 6\u2019s\u0131nda kronik b\u00f6brek hastal\u0131\u011f\u0131 g\u00f6r\u00fcl\u00fcyor.<\/p>\n\n\n\n

\u201c\u00dclkemizde y\u0131lda yakla\u015f\u0131k 3 bin 500\u2019\u00fcn \u00fczerinde b\u00f6brek nakli ger\u00e7ekle\u015ftirilmektedir\u201d<\/strong><\/p>\n\n\n\n

Bas\u0131n toplant\u0131s\u0131nda T\u00fcrkiye\u2019de b\u00f6brek nakli hakk\u0131nda bilgiler veren T\u00fcrk Nefroloji Derne\u011fi Ba\u015fkan\u0131 Prof. Dr. Alaattin Y\u0131ld\u0131z, \u201c<\/strong>B\u00f6brek nakli, ileri evre b\u00f6brek yetersizli\u011finin en se\u00e7kin tedavisidir. B\u00f6brek fonksiyonlar\u0131n\u0131n tamam\u0131n\u0131 hastaya kazand\u0131rd\u0131\u011f\u0131 i\u00e7in kalp ve damar sa\u011fl\u0131\u011f\u0131 \u00fczerine olumlu etkileri vard\u0131r. Bu nedenle beklenen ya\u015fam s\u00fcresi diyaliz tedavisi g\u00f6rmekte olan hastalara g\u00f6re \u00e7ok daha uzundur. \u00dclkemizde y\u0131lda yakla\u015f\u0131k 3 bin 500\u2019\u00fcn \u00fczerinde b\u00f6brek nakli ger\u00e7ekle\u015ftirilmektedir. B\u00f6brek nakli \u00fclkemizde y\u00fcksek uluslararas\u0131 standartta \u00e7ok ba\u015far\u0131l\u0131 oldu\u011fundan, nakillerin yakla\u015f\u0131k y\u00fczde 10\u2019u yurt d\u0131\u015f\u0131ndan gelen hastalara sa\u011fl\u0131k turizmi kapsam\u0131nda yap\u0131lmaktad\u0131r. B\u00f6brek naklinin ba\u015far\u0131s\u0131, ameliyat \u00f6ncesi d\u00f6nemde al\u0131c\u0131n\u0131n ve vericinin ayr\u0131nt\u0131l\u0131 olarak de\u011ferlendirilmesi ile ba\u015flar. B\u00f6ylece nakil sonras\u0131 geli\u015febilecek sorunlar \u00f6ng\u00f6r\u00fclebilir ve b\u00f6brekler erkenden ba\u015far\u0131l\u0131 bir \u015fekilde verilebilir. Nakil sonras\u0131 erken d\u00f6nem, \u00f6zellikle ilk bir ay \u00e7ok \u00f6nemlidir. Bu d\u00f6nemin hastan\u0131n yak\u0131n takibi ile sorunsuz ge\u00e7irilmesi, b\u00f6bre\u011fin uzun d\u00f6nem \u00f6mr\u00fcn\u00fc belirler. Daha sonraki d\u00f6nemde de nakil hastas\u0131n\u0131n daha uzun aral\u0131klarla nefrolojik takibi, geli\u015febilecek komplikasyonlar\u0131n \u00f6nlenebilmesi ve erkenden tedavi edilmesi a\u00e7\u0131s\u0131ndan \u00f6nemlidir\u201d dedi.<\/p>\n\n\n\n

\u201cEri\u015fkin n\u00fcfusta kronik b\u00f6brek hastal\u0131\u011f\u0131n\u0131n s\u0131kl\u0131\u011f\u0131 y\u00fczde 10\u2019un \u00fczerinde\u201d<\/strong><\/p>\n\n\n\n

T\u00fcrkiye\u2019de kronik b\u00f6brek hastal\u0131\u011f\u0131na dikkat \u00e7eken T\u00fcrk Nefroloji Derne\u011fi Ba\u015fkan Yard\u0131mc\u0131s\u0131 Prof. Dr. Nurhan Seyahi, <\/strong>\u201c\u00dclkemizde T\u00fcrk Nefroloji Derne\u011fi\u2019nin b\u00fcnyesinde y\u00fcr\u00fct\u00fclm\u00fc\u015f olan CREDIT \u00c7al\u0131\u015fmas\u0131\u2019na g\u00f6re eri\u015fkin n\u00fcfusta kronik b\u00f6brek hastal\u0131\u011f\u0131n\u0131n s\u0131kl\u0131\u011f\u0131 y\u00fczde 10\u2019un \u00fczerindedir. Hastal\u0131\u011fa bu kadar s\u0131k rastlanmas\u0131na ra\u011fmen tan\u0131n\u0131n konulamamas\u0131 \u00f6zellikle erken evrelerinde hastal\u0131\u011f\u0131n herhangi bir bulguya yol a\u00e7madan sessiz seyretmesindendir. Bu durum erken tan\u0131 i\u00e7in en az\u0131dan risk alt\u0131ndaki bireylerde tarama testlerinin yap\u0131lmas\u0131n\u0131 gerekli k\u0131lmaktad\u0131r. Tarama yap\u0131lmas\u0131 gerekli gruplar hakk\u0131nda kesin bir g\u00f6r\u00fc\u015f birli\u011fi olmasa da \u015feker ve y\u00fcksek tansiyon hastalar\u0131nda b\u00f6brek hastal\u0131\u011f\u0131 y\u00f6n\u00fcnden mutlaka belirli aral\u0131klara kan ve idrar tahlili ile tarama yap\u0131lmas\u0131 gereklidir. Ayr\u0131ca ya\u015fl\u0131larda, ailesinde b\u00f6brek hastal\u0131\u011f\u0131 hik\u00e2yesi olanlarda, romatolojik hastal\u0131\u011f\u0131 olanlarda b\u00f6brek hastal\u0131\u011f\u0131 y\u00f6n\u00fcnden tarama yap\u0131lmal\u0131d\u0131r. Erken tan\u0131 ve zaman\u0131nda ba\u015flanan tedavi ile g\u00fcn\u00fcm\u00fczde kronik b\u00f6brek hastal\u0131\u011f\u0131n\u0131n ilerlemesi yava\u015flat\u0131labilmekte ve son d\u00f6nem b\u00f6brek yetmezli\u011finin geli\u015fmesi engellenebilmektedir. B\u00f6brek yetmezli\u011fine yani diyaliz veya b\u00f6brek nakline gidi\u015f s\u00fcrecini yava\u015flatabilecek ya\u015fam tarz\u0131 de\u011fi\u015fikliklerinin yan\u0131 s\u0131ra \u00fclkemizde de bulunan ila\u00e7 tedavisi se\u00e7eneklerinin belirlenmesi ve uygulamas\u0131 i\u00e7in bir nefrolog taraf\u0131ndan d\u00fczenli takip elzemdir.B\u00f6breklerimizin kan\u0131 s\u00fczerek olu\u015fturdu\u011fu idrar ile v\u00fccut i\u00e7in zararl\u0131 maddeleri uzakla\u015ft\u0131rd\u0131\u011f\u0131 yayg\u0131n olarak bilinmektedir. Ancak bunun yan\u0131 s\u0131ra kan yap\u0131m\u0131, kan bas\u0131nc\u0131n\u0131n d\u00fczenlenmesi, kemik sa\u011fl\u0131\u011f\u0131, v\u00fccuttaki asit miktar\u0131n\u0131n dengelenmesi gibi bir\u00e7ok ya\u015famsal g\u00f6rev de b\u00f6breklerimiz taraf\u0131ndan y\u00fcr\u00fct\u00fcl\u00fcr. Yine v\u00fccuttaki sodyum ve potasyum gibi elektrolitlerin seviyeleri de ba\u015fl\u0131ca b\u00f6breklerimiz taraf\u0131ndan ayarlan\u0131r. Bu nedenle b\u00f6brek hastalar\u0131nda v\u00fccut tuzlar\u0131ndaki dengesizliklere s\u0131k olarak rastlan\u0131l\u0131r. Bunun yan\u0131 s\u0131ra \u00f6zellikle b\u00f6brek hastal\u0131\u011f\u0131n\u0131n ilerlemesini engellemek i\u00e7in kullan\u0131lan yararl\u0131 baz\u0131 ila\u00e7lar da v\u00fccutta potasyum dengesini bozabilir, bu durum \u00f6zellikle \u015feker hastalar\u0131nda daha belirgin olabilir.Nefrolo\u011fun d\u00fczenli yapt\u0131\u011f\u0131 takip ve de\u011ferlendirme s\u00fcrecinde hastalar\u0131m\u0131z bu a\u00e7\u0131lardan da de\u011ferlendirilmekte ve tedavileri d\u00fczenlenmektedir\u201d dedi.<\/p>\n\n\n\n

\u201cDo\u011furma \u00e7a\u011f\u0131ndaki kad\u0131nlar\u0131n y\u00fczde 6\u2019s\u0131nda kronik b\u00f6brek hastal\u0131\u011f\u0131 g\u00f6r\u00fcl\u00fcyor\u201d<\/strong><\/p>\n\n\n\n

T\u00fcrk Nefroloji Derne\u011fi Genel Sekreteri Prof. Dr. Elif Ar\u0131 Bak\u0131r, <\/strong>kad\u0131nlarda b\u00f6brek sa\u011fl\u0131\u011f\u0131 konulu konu\u015fmas\u0131nda \u015funlar\u0131 s\u00f6yledi: \u201cKronik b\u00f6brek hastal\u0131\u011f\u0131, do\u011furma \u00e7a\u011f\u0131ndaki kad\u0131nlar\u0131n y\u00fczde 6\u2019s\u0131nda g\u00f6r\u00fcl\u00fcr. Hafif-orta kronik b\u00f6brek hastal\u0131\u011f\u0131 olan kad\u0131nda gebelik, b\u00f6brek fonksiyonlar\u0131n\u0131 olumsuz etkileyebilece\u011fi gibi, gebelik sonras\u0131 b\u00f6brek fonksiyonlar\u0131 eski haline gelebilir. Ama yap\u0131lan \u00e7al\u0131\u015fmalar g\u00f6stermektedir ki, ileri b\u00f6brek yetmezli\u011fi olan kad\u0131nda gebelik s\u00fcresince b\u00f6brek hastal\u0131\u011f\u0131 da ilerlemekte ve diyaliz a\u015famas\u0131na getirebilmektedir. Diyalize giren bir kad\u0131n gebe kald\u0131\u011f\u0131nda, bebe\u011fi olu\u015fabilen toksit at\u0131klar\u0131n etkilerinden uzak tutabilmek i\u00e7in haftada 20 saat hemodiyalize al\u0131nmas\u0131 \u00f6nerilmektedir. G\u00fcnl\u00fck hemodiyaliz, gebe kad\u0131nda istenmeyen potasyum y\u00fcksekli\u011fi (hiperpotasemi), metabolik asidoz gibi komplikasyonlar\u0131 engeller. \u00c7ok yak\u0131n zamanda yay\u0131nlanan bir derlemeye g\u00f6re anne ve bebeklerde \u00f6l\u00fcm oranlar\u0131n\u0131 azaltt\u0131\u011f\u0131 kesin olmamakla birlikte haftada 5-6 g\u00fcn, g\u00fcnl\u00fck 4 saat hemodiyaliz, gebe diyaliz hastalar\u0131na \u00f6nerilmektedir.\u201d<\/p>\n\n\n\n

\u201c68 binin \u00fczerinde hasta b\u00f6brek yetersizli\u011fi nedeniyle diyaliz tedavisi g\u00f6r\u00fcyor\u201d<\/strong><\/p>\n\n\n\n

Konu\u015fmas\u0131nda \u00fclkemizde diyaliz tedavileri hakk\u0131nda rakamlar payla\u015fan T\u00fcrk Nefroloji Derne\u011fi Sayman\u0131 Prof. Dr. Ali R\u0131za Odaba\u015f, <\/strong>\u201c\u00dclkemizde bu y\u0131l itibar\u0131yla yakla\u015f\u0131k olarak 68.000\u2019in \u00fczerinde hasta son d\u00f6nem b\u00f6brek yetersizli\u011fi nedeniyle diyaliz tedavisi g\u00f6rmektedir. Bu hastalardan 64 bin 300 tanesi hemodiyaliz, 3 bin 250 tanesi periton diyalizi, 1.300 tanesi ise ev hemodiyalizi ile tedavi edilmektedirler. \u015eu anda \u00fclkemiz ev hemodiyalizi hasta say\u0131s\u0131 a\u00e7\u0131s\u0131ndan Avrupa\u2019da ikinci, d\u00fcnyada ise \u00fc\u00e7\u00fcnc\u00fc s\u0131rada bulunmaktad\u0131r. \u00dclkemizde say\u0131lar\u0131 68.000\u2019i ge\u00e7en hemodiyaliz hastalar\u0131n\u0131n bir\u00e7o\u011funda \u015feker hastal\u0131\u011f\u0131, hipertansiyon, kalp ve damar hastal\u0131klar\u0131 gibi e\u015flik eden hastal\u0131klar mevcuttur. Bu hastalar\u0131n infeksiyonlara e\u011filimleri y\u00fcksektir ve ba\u015fta kalp hastal\u0131klar\u0131 olmak \u00fczere hayat\u0131 tehdit eden sorunlarla s\u0131kl\u0131kla kar\u015f\u0131la\u015f\u0131lmaktad\u0131r. Ayr\u0131ca b\u00f6brek yetersizli\u011fi ile ili\u015fkili kemik sorunlar\u0131, hemodiyalize girebilmek i\u00e7in damar giri\u015f yolu ile ilgili sorunlar, damarlarda kire\u00e7lenmeye ba\u011fl\u0131 t\u0131kan\u0131kl\u0131klar gibi ciddi sorunlar da s\u0131k\u00e7a g\u00f6r\u00fcl\u00fcr. K\u0131saca takibi ve tedavisi zor, hekim tecr\u00fcbesi ve iyi y\u00f6netim gerektiren bir hasta grubudur.\u201d<\/p>\n\n\n\n

\u201cD\u00fcnya genelinde yakla\u015f\u0131k 850 milyon kronik b\u00f6brek hastas\u0131 var\u201d<\/strong><\/p>\n\n\n\n

D\u00fcnyada kronik b\u00f6brek hastal\u0131\u011f\u0131konusunda konu\u015fan T\u00fcrk Nefroloji Derne\u011fi Y\u00f6netim Kurulu \u00dcyesi Prof. Dr. Mustafa Ar\u0131c\u0131 <\/strong>\u015funlar\u0131 s\u00f6yledi: <\/strong>\u201cD\u00fcnya genelinde yakla\u015f\u0131k 850 milyon kronik b\u00f6brek hastas\u0131 vard\u0131r. Bu say\u0131, d\u00fcnya genelindeki diyabet hastas\u0131 say\u0131s\u0131n\u0131n 2 kat\u0131, kanser hastas\u0131 say\u0131s\u0131n\u0131n ise 8 kat\u0131d\u0131r. Bir ba\u015fka deyi\u015fle d\u00fcnyada her 10 ki\u015fiden 1\u2019inde b\u00f6brek hastal\u0131\u011f\u0131 mevcuttur. Bu \u00f6zelli\u011fi ile kronik b\u00f6brek hastal\u0131\u011f\u0131, kronik hastal\u0131klar aras\u0131nda ne yaz\u0131k ki en \u00f6n s\u0131rada yer almaktad\u0131r. Kronik b\u00f6brek hastal\u0131\u011f\u0131, kalp damar hastal\u0131\u011f\u0131 ve \u00f6l\u00fcm riskinin olduk\u00e7a y\u00fcksek oldu\u011fu bir durumdur. Di\u011fer bir\u00e7ok hastal\u0131kla kar\u015f\u0131la\u015ft\u0131r\u0131ld\u0131\u011f\u0131nda 2000 y\u0131l\u0131ndan 2019 y\u0131l\u0131na, k\u00fcresel olarak en h\u0131zl\u0131 b\u00fcy\u00fcyen \u00fc\u00e7\u00fcnc\u00fc \u00f6l\u00fcm nedeni, b\u00f6brek hastal\u0131\u011f\u0131d\u0131r. Bu h\u0131z\u0131n devam etmesi durumunda 2040 y\u0131l\u0131na gelindi\u011finde kronik b\u00f6brek hastal\u0131\u011f\u0131n\u0131n d\u00fcnya \u00e7ap\u0131nda ya\u015fam kayb\u0131 nedenleri aras\u0131nda 5. s\u0131raya y\u00fckselece\u011fi tahmin edilmektedir. Ancak nefrologlar\u0131n liderli\u011fi ile ger\u00e7ekle\u015ftirilecek toplumsal bir m\u00fccadele sonucunda kronik b\u00f6brek hastal\u0131\u011f\u0131 riskinin azalt\u0131lmas\u0131 m\u00fcmk\u00fcn olabilecektir.\u201d<\/p>\n\n\n\n

\u201cKahramanmara\u015f merkezli depremde ezilme sendromlu hastalar\u0131n y\u00fczde 68\u2019inde akut b\u00f6brek yetmezli\u011fi geli\u015fti\u201d<\/strong><\/p>\n\n\n\n

T\u00fcrk Nefroloji Derne\u011fi Y\u00f6netim Kurulu \u00dcyesi Prof. Dr. \u00d6zkan G\u00fcng\u00f6r, <\/strong>do\u011fal afetlerde nefroloji konulu konu\u015fmas\u0131nda, \u201cKahramanmara\u015f merkezli depremin etkisini g\u00f6sterdi\u011fi 11 ilde baz\u0131 diyaliz merkezleri y\u0131k\u0131lm\u0131\u015f veya elektrik ve su kesintisi nedeniyle \u00e7al\u0131\u015fmaz halde idi. Depremin ilk 2 g\u00fcn\u00fc Kahramanmara\u015f ilinin b\u00fct\u00fcn kronik diyaliz hastalar\u0131n\u0131n tedavilerinin devam etmesi i\u00e7in 24 saat hizmet verdik, di\u011fer illerde de diyaliz merkezleri bu \u015fekilde \u00e7al\u0131\u015ft\u0131. Bu arada hasar g\u00f6ren diyaliz merkezleri ve su sistemleri h\u0131zla \u00e7al\u0131\u015f\u0131r duruma getirildi. \u00dclkemizin d\u00f6rt bir yan\u0131ndan nefroloji uzmanlar\u0131 ve diyaliz hem\u015fireleri h\u0131zla deprem b\u00f6lgesine gelip diyaliz hizmeti sunulmas\u0131na \u00e7al\u0131\u015ft\u0131. Di\u011fer yandan deprem b\u00f6breklere de zarar verebiliyor. Depremde kas ezilmesi nedeni ile hayat\u0131 tehdit eden \u2018Ezilme Sendromu\u2019 ortaya \u00e7\u0131kabilmektedir. Ezilme sendromlu hastalarda ani \u00f6l\u00fcmlere de neden olan ciddi h\u0131zl\u0131 geli\u015fen b\u00f6brek yetersizli\u011fi ve potasyum y\u00fcksekli\u011fi gibi durumlar geli\u015febilmektedir. Bu hastalara h\u0131zla diyaliz uygulamalar\u0131 hayat kurtar\u0131c\u0131d\u0131r. T\u00fcrk Nefroloji Derne\u011fi verilerine g\u00f6re bu depremde kay\u0131tl\u0131 1024 ezilme sendromlu hastan\u0131n oldu\u011fu, hastalar\u0131n y\u00fczde 68\u2019inde akut b\u00f6brek yetmezli\u011fi geli\u015fti\u011fi, 635 hastaya 3016 seans hemodiyaliz i\u015flemi yap\u0131ld\u0131\u011f\u0131 anla\u015f\u0131lmaktad\u0131r\u201d dedi.<\/p>\n\n\n\n

\u201cTND Sosyal Medya platformlar\u0131m\u0131zla t\u00fcm vatanda\u015flar\u0131m\u0131z\u0131n yan\u0131nday\u0131z\u201d<\/strong><\/p>\n\n\n\n

T\u00fcrk Nefroloji Derne\u011fi Y\u00f6netim Kurulu \u00dcyesi Prof. Dr. Sena Ulu <\/strong>b\u00f6brek sa\u011fl\u0131\u011f\u0131 ve sosyal medyan\u0131n \u00f6nemi konusunda \u015funlar\u0131 s\u00f6yledi: \u201cSosyal medya, bilgilendirme kampanyalar\u0131n\u0131 h\u0131zl\u0131 ve etkili bir \u015fekilde yayma g\u00fcc\u00fcne sahiptir. T\u00fcrk Nefroloji Derne\u011fi, bu bilin\u00e7le t\u00fcm sosyal medya platformlar\u0131nda y\u0131llardan beri g\u00fc\u00e7l\u00fc bir \u015fekilde var olmu\u015f, bir yandan halka y\u00f6nelik bilgilendirme, fark\u0131ndal\u0131k ve e\u011fitim faaliyetlerinde bulunurken, bir yandan da dernek faaliyetlerinin duyurular\u0131n\u0131 sa\u011flam\u0131\u015f ve sa\u011fl\u0131k \u00e7al\u0131\u015fanlar\u0131n\u0131n e\u011fitim faaliyetlerine katk\u0131da bulunmu\u015ftur. TND ge\u00e7ti\u011fimiz y\u0131l, ba\u015far\u0131l\u0131 projeler ger\u00e7ekle\u015ftirmi\u015f ve projelerimiz \u00f6d\u00fclle ta\u00e7land\u0131r\u0131lm\u0131\u015ft\u0131r. Bunlardan ilki, T\u00fcrkiye\u2019de bir ilk olan AstraZeneca T\u00fcrkiye\u2019nin ko\u015fulsuz destekleri ile hayata ge\u00e7irdi\u011fimiz \u201cSa\u011fl\u0131kl\u0131 B\u00f6brek Sa\u011fl\u0131kl\u0131 Hayat\u201d projesi olmu\u015ftur. Proje kapsam\u0131nda 4 farkl\u0131 lokasyonda 3 bin kat\u0131l\u0131mc\u0131ya h\u0131zl\u0131 idrar testi, kilo ve tansiyon \u00f6l\u00e7\u00fcm\u00fc uyguland\u0131 ve \u00e7arp\u0131c\u0131 sonu\u00e7lar elde edildi. Kat\u0131l\u0131mc\u0131lar\u0131n y\u00fczde 51\u2019inde kronik b\u00f6brek hastal\u0131\u011f\u0131 riski, y\u00fczde 18\u2019inin ise orta-y\u00fcksek riskli grupta olduklar\u0131 tespit edildi. Projemizin ikinci aya\u011f\u0131nda ise AstraZeneca T\u00fcrkiye ve Danone\u2019un ko\u015fulsuz katk\u0131lar\u0131yla yenilik\u00e7i bir fark\u0131ndal\u0131k projesine imza att\u0131k. Projemiz kapsam\u0131nda, Hayat Su ile i\u015f birli\u011fi yaparak su \u015fi\u015felerine ve evlere sipari\u015f damacanalara giydirme ile bir QR kod ekledik. Bu QR kod tarat\u0131ld\u0131\u011f\u0131nda eri\u015filebilen \u201cB\u00f6brekleriniz Sa\u011fl\u0131kl\u0131 m\u0131?\u201d testi ile kronik b\u00f6brek hastal\u0131\u011f\u0131 a\u00e7\u0131s\u0131ndan riskli hastalar\u0131m\u0131z\u0131 hekimlerimize y\u00f6nlendirmeyi ama\u00e7lad\u0131k ve 100 bin ki\u015fiye ula\u015ft\u0131k. Ayn\u0131 zamanda bu projemizin \u0130stanbul Marketing Summit taraf\u0131ndan Marka \u0130\u015f Birlikleri kategorisinde 1.\u2019lik \u00f6d\u00fcl\u00fcne l\u00e2y\u0131k g\u00f6r\u00fcld\u00fc\u011f\u00fcn\u00fc sizlerle payla\u015fmaktan mutluluk duyuyoruz.<\/p>\n\n\n\n

Di\u011fer yandan T\u00fcrk Nefroloji Derne\u011fi\u2019nin Instagram hesab\u0131, X ve LinkedIn hesab\u0131 yan\u0131nda, hekimler ve sa\u011fl\u0131k \u00e7al\u0131\u015fanlar\u0131 i\u00e7in Nefroloji TV, halka y\u00f6nelik e\u011fitici videolar\u0131n bulundu\u011fu T\u00fcrk Nefroloji Derne\u011fi YouTube kanal\u0131 aktif olarak faaliyetlerini s\u00fcrd\u00fcrmektedir. Bu kanallar arac\u0131l\u0131\u011f\u0131yla bir yandan hasta e\u011fitimi amac\u0131yla nefroloji alan\u0131ndaki profesyoneller ve hastalar aras\u0131nda bir k\u00f6pr\u00fc olu\u015fturulmakta, hastalar\u0131m\u0131z nefroloji uzmanlar\u0131m\u0131z\u0131n kontrol\u00fcnde g\u00fcvenilir bir platform bulabilmektedir. TND sosyal medya platformlar\u0131m\u0131zla t\u00fcm vatanda\u015flar\u0131m\u0131z\u0131n yan\u0131nda olmaya devam edece\u011fiz.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"

T\u00fcrk Nefroloji Derne\u011fi, kronik b\u00f6brek hastal\u0131\u011f\u0131n\u0131n \u00f6nemine dikkat \u00e7ekmek i\u00e7in belirlenen D\u00fcnya B\u00f6brek G\u00fcn\u00fc kapsam\u0131nda t\u00fcm y\u00f6netim kurulu \u00fcyelerinin kat\u0131l\u0131m\u0131yla \u201cB\u00f6brek Cand\u0131r\u201d temal\u0131 bir bas\u0131n toplant\u0131s\u0131 d\u00fczenledi. Bas\u0131n toplant\u0131s\u0131nda kronik b\u00f6brek hastal\u0131\u011f\u0131na dair toplumda fark\u0131ndal\u0131k sa\u011flamak, kronik b\u00f6brek hastal\u0131\u011f\u0131na yol a\u00e7an risk fakt\u00f6rleri ve erken tan\u0131n\u0131n b\u00f6brek fonksiyonunu korumadaki \u00f6nemine dikkat \u00e7ekmek \u00fczere bilgiler payla\u015f\u0131ld\u0131.<\/p>\n","protected":false},"author":1,"featured_media":3049,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[48,42],"tags":[],"_links":{"self":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/3048"}],"collection":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3048"}],"version-history":[{"count":1,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/3048\/revisions"}],"predecessor-version":[{"id":3050,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/3048\/revisions\/3050"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/media\/3049"}],"wp:attachment":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3048"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3048"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3048"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}